Medical News

RSS

Tanner Pharma Group to attend CTS Europe, DCAT, PharmagoraPlus, PQMD, and GCSG US conferences

Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several international healthcare conferences throughout the upcoming months of March and April.

From Tanner Pharma Group 29 Aug 2019

Tanner Pharma Group signs distribution agreement with Nephcentric LLC

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.

From Tanner Pharma Group 29 Aug 2019

Tanner Pharma Group signs distribution agreement with MannKind Corporation

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with MannKind Corporation, a biopharmaceutical company focused on inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension.

From Tanner Pharma Group 29 Aug 2019

Claims that cesarean sections increase the risk of autism are “highly unlikely”, say experts

Recent research into over 20 million births concluded that babies born by Cesarean section are more likely to develop autism has divided the medical community.

29 Aug 2019

Graphene-lined fabric could slow the spread of malaria

Lining clothes with graphene could prevent the spread of malaria as mosquitoes are not able to pick up on chemical signals that encourage them to bite.

29 Aug 2019

Intrinsic night vision could be on the horizon for humans

Scientists have used nanoparticles to develop the ability to see near-infrared light in mice.

29 Aug 2019

We still don't understand the full impact of prenatal opioid exposure on childhood development

While the opioid epidemic has been reported on extensively, data on the effects of prenatal opioid exposure on childhood development is still lacking.

29 Aug 2019

DNA vaccine for tick-borne disease ‘SFTS’ confers protection against lethal infection in ferrets

A KAIST research team reported the development of a DNA vaccine for Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) which completely protects against lethal infection in ferrets.

29 Aug 2019

New optical technology heralds exciting potential for mammalian behavioral studies

In an article published in the peer-reviewed, open-access SPIE publication Neurophotonics, "A multi-site microLED optrode array for neural interfacing," researchers present an implantable optrode array capable of exciting below-surface neurons in large mammal brains at two levels, both by structured-light delivery and large-volume illumination.

29 Aug 2019

Researchers analyze people’s initial immune response to dengue fever

Researchers have come one step closer to understanding how our immune system responds to acute dengue fever, a disease that has affected hundreds of thousands of people in Southeast Asia this summer alone.

29 Aug 2019

New type 2 diabetes drug associated with reduced risk of heart failure and death

The new type of drugs for type 2 diabetes, the so-called SGLT2 inhibitors, are associated with a reduced risk of heart failure and death as well as of major cardiovascular events, a major Scandinavian registry study led from Karolinska Institutet reports in The BMJ.

29 Aug 2019

New 'ETAK Antimicrobial Wet Wipes' for elimination of viruses, bacteria on personal belongings

Eisai Co., Ltd. will launch ETAK( Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-acting antimicrobial agent ETAK on August 29, 2019 at pharmacies and drugstores countrywide.

From Eisai 29 Aug 2019

Bone 3D selects Stratasys J750 3D Printer to produce highly precise medical models

French manufacturer, Bone 3D, has installed a Stratasys J750 3D Printer after identifying its full color, multi-material attributes as the solution to strengthen its capabilities and quickly produce highly precise medical and orthodontic models for its customers.

From Stratasys 29 Aug 2019

Cancer cells ‘corrupt’ their healthy neighbors to support tumor growth

The healthy cells immediately surrounding a tumor become more stem cell-like and support cancer growth, reveals a new study published in Nature.

From The Francis Crick Institute 29 Aug 2019

Community-based wildlife mortality surveillance program could help prevent Ebola outbreaks

Human Ebola epidemics, like the current outbreak in the Democratic Republic of Congo, are known to start from a contact with wildlife infected with Ebola virus. In

29 Aug 2019

Gout patients have higher risk of advanced kidney disease, study finds

Patients with gout are at increased risk of chronic kidney disease and kidney failure, according to new University of Limerick (UL), Ireland led research.

29 Aug 2019

MUSC researchers narrow down risk of preeclampsia to a specific phenotype

The force of blood traveling through your arteries and veins determines much of your heart health. High blood pressure can lead to heart disease, heart failure, heart attack, stroke and chronic kidney disease, and when it's coupled with type 1 diabetes and pregnancy, it can put both the mother and the baby at risk.

29 Aug 2019

Indoor bacterial microbiota may protect children from asthma

Large amounts of a certain type of bacteria, most likely from outdoors, may reduce the child's risk of developing asthma. This was shown by Finnish Institute for Health and Welfare's (THL) new study that analysed the microbiota in over 400 Finnish homes.

29 Aug 2019

Researchers shed new light on how the brain constructs itself

The cerebral cortex acts as the control center of our cognitive processes. During embryogenesis, dozens of types of neurons with distinct functions come together to form the circuits that drive our thoughts and actions.

29 Aug 2019

Early planned delivery reduces impact of preterm pre-eclampsia

Doctors have long debated over the optimal time to deliver mothers with pre-eclampsia in late pregnancy (after 34 but before 37 completed weeks). This is because too early delivery compromises the baby’s health, while delayed action may endanger the mother’s health.

29 Aug 2019

Medical News

Tanner Pharma Group to attend CTS Europe, DCAT, PharmagoraPlus, PQMD, and GCSG US conferences

Tanner Pharma Group signs distribution agreement with Nephcentric LLC

Tanner Pharma Group signs distribution agreement with MannKind Corporation

Claims that cesarean sections increase the risk of autism are “highly unlikely”, say experts

Graphene-lined fabric could slow the spread of malaria

Intrinsic night vision could be on the horizon for humans

We still don't understand the full impact of prenatal opioid exposure on childhood development

DNA vaccine for tick-borne disease ‘SFTS’ confers protection against lethal infection in ferrets

New optical technology heralds exciting potential for mammalian behavioral studies

Researchers analyze people’s initial immune response to dengue fever

New type 2 diabetes drug associated with reduced risk of heart failure and death

New 'ETAK Antimicrobial Wet Wipes' for elimination of viruses, bacteria on personal belongings

Bone 3D selects Stratasys J750 3D Printer to produce highly precise medical models

Cancer cells ‘corrupt’ their healthy neighbors to support tumor growth

Community-based wildlife mortality surveillance program could help prevent Ebola outbreaks

Gout patients have higher risk of advanced kidney disease, study finds

MUSC researchers narrow down risk of preeclampsia to a specific phenotype

Indoor bacterial microbiota may protect children from asthma

Researchers shed new light on how the brain constructs itself

Early planned delivery reduces impact of preterm pre-eclampsia

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News